Instalimb Secures Funding to Revolutionize Prosthetics with AI and 3D Printing

Instalimb's Groundbreaking Approach to Prosthetics

Instalimb Corporation, headquartered in Sumida, Tokyo, is pioneering the use of AI and 3D printing technologies to manufacture prosthetic limbs. They have recently completed a funding round with Ortomos Investment, which will serve as a critical foundation for their operations in Japan, marking a significant step in the company’s vision to provide high-quality prosthetics to those in need.

Recognizing a growing need for affordable and innovative prosthetic solutions, Instalimb aims to expand its operations into the Japanese market while continuing its successful initiatives in India and the Philippines. With a mission to ensure that everyone has access to quality prosthetics, Instalimb operates three business pillars: a clinic for direct sales of 3D-printed prosthetic limbs, a licensing business to provide 3D design and manufacturing solutions, and a franchise model to offer end-to-end services cultivated through their clinic experiences.

A Shift Towards Local Empowerment

The partnership with Ortomos Investment and the signing of the basic agreement with Alcare, a prominent company in the Japanese medical industry founded in 1955, marks a turning point for Instalimb. The collaboration aims to leverage digital manufacturing technologies and expertise to overcome challenges that are unique to the Japanese market, such as ensuring the suitability of prosthetic sockets and maintaining a sustainable supply chain in advanced medical settings.

Instalimb’s commitment extends beyond funding; it encompasses a holistic approach to revolutionizing how prosthetics are conceived and delivered. By combining their advanced manufacturing techniques with decades of industry know-how from Alcare, they plan to innovate in three key areas:

1. Adjustable Prosthetic Socket Solutions: Using AI and 3D technologies, they will explore new ways to create prosthetic sockets that allow for customizable fits, addressing challenging cases with precision and personal comfort.
2. Accessible Development of Medical Aids: In light of the aging population and chronic diseases resulting in bodily deformities, Instalimb seeks to produce long-lasting aids that can adapt over time, revolutionizing how assistive technologies are developed.
3. Joint Venture for Market Expansion: Together, they will investigate the commercialization of prosthetic technologies tailored for the Japanese market, with possibilities for franchising models that embrace digital advancements.

Overcoming Challenges and Expanding Horizons

Despite their successes in Southeast Asia, Instalimb is acutely aware of the unique hurdles within the Japanese healthcare system. The sophistication of healthcare provision and the specificity needed for prosthetic devices highlight the necessity for innovation and collaboration within the industry. The partnership with Ortomos and Alcare is not just about business growth; it’s about creating impactful solutions that respond to these intricate needs.

Since its establishment in 2017, Instalimb has emerged as a global player, having successfully delivered over 9,000 prosthetic limbs in regions like the Philippines and India. Their breakthrough 3D-printed prosthetics not only match traditional products in quality but do so at a fraction of the cost, enhancing accessibility for those requiring prosthetics.

Looking Ahead

Instalimb’s future looks bright as they continue to push boundaries in both emerging markets and developed ones. By integrating their operations within Japan’s healthcare framework, they plan to provide tailored prosthetic solutions that enhance the quality and accessibility of healthcare for all.

With a steadfast vision, Instalimb is committed to innovating the prosthetic landscape, ensuring that anyone in need can obtain high-quality prosthetic aids. They see the upcoming developments as crucial steps towards realizing a world where quality prosthetics are readily available to everyone, emphasizing their dual commitment to global and local challenges alike.